e 4031 has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 7 studies
E 4031: class III anti-arrhythmia agent; structure given in UD
| Excerpt | Relevance | Reference |
|---|---|---|
| "The most common mechanism of sustained ventricular tachycardia (VT) is re-entry with an excitable gap, but the electrophysiologic properties and response to antiarrhythmic drugs in the area of slow conduction are not yet fully known." | 1.30 | Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing. ( Aizawa, Y; Naitoh, N; Takahashi, K; Washizuka, T, 1998) |
| "Six patients had sustained ventricular tachycardia (VT) and 5 had ventricular fibrillation (VF)." | 1.30 | Comparison of electrophysiologic effects of intravenous E-4031 and MS-551, novel class III antiarrhythmic agents, in patients with ventricular tachyarrhythmias. ( Aizawa, Y; Furushima, H; Naitoh, N; Tagawa, M; Taneda, K; Yamaura, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, L | 1 |
| Rajamani, S | 1 |
| Li, H | 1 |
| January, CT | 1 |
| Shryock, JC | 1 |
| Belardinelli, L | 1 |
| Izumi, D | 1 |
| Chinushi, M | 1 |
| Iijima, K | 1 |
| Ahara, S | 1 |
| Komura, S | 1 |
| Furushima, H | 2 |
| Hosaka, Y | 1 |
| Sanada, A | 1 |
| Yagihara, N | 1 |
| Aizawa, Y | 3 |
| Yamauchi, S | 2 |
| Yamaki, M | 2 |
| Watanabe, T | 2 |
| Yuuki, K | 1 |
| Kubota, I | 2 |
| Tomoike, H | 2 |
| Ogawa, S | 1 |
| Mitamura, H | 1 |
| Katoh, H | 1 |
| Naitoh, N | 2 |
| Washizuka, T | 1 |
| Takahashi, K | 1 |
| Tagawa, M | 1 |
| Yamaura, M | 1 |
| Taneda, K | 1 |
| Miyashita, T | 1 |
7 other studies available for e 4031 and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart.
Topics: 4-Aminopyridine; Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Barium Compounds; | 2009 |
Effects of bepridil versus E-4031 on transmural ventricular repolarization and inducibility of ventricular tachyarrhythmias in the dog.
Topics: Animals; Anti-Arrhythmia Agents; Bepridil; Blood Pressure; Calcium Channel Blockers; Cerebral Revasc | 2010 |
Restitution properties and occurrence of ventricular arrhythmia in LQT2 type of long QT syndrome.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disease Models, Animal; Disease Suscept | 2002 |
Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disease Models, Animal; Disopyrami | 1993 |
Effects of class I and III antiarrhythmic drugs on ventricular tachycardia-interrupting critical paced cycle length with rapid pacing.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Child; Electrophysiology; Female; Heart | 1998 |
Comparison of electrophysiologic effects of intravenous E-4031 and MS-551, novel class III antiarrhythmic agents, in patients with ventricular tachyarrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; | 1998 |
4-aminopyridine inhibits the occurrence of ventricular fibrillation but not ventricular tachycardia in the reperfused, P6olated rat heart.
Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Blood Flow Velocity; Glyburide; Heart; Heart Rate; | 2000 |